PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study (Q46639344)
Jump to navigation
Jump to search
scientific article published on 5 August 2005
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study |
scientific article published on 5 August 2005 |
Statements
1 reference
PS-341 and gemcitabine in patients with metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group (NCCTG) randomized phase II study (English)
1 reference
S R Alberts
1 reference
N R Foster
1 reference
R F Morton
1 reference
J Kugler
1 reference
P Schaefer
1 reference
M Wiesenfeld
1 reference
T R Fitch
1 reference
P Steen
1 reference
G P Kim
1 reference
S Gill
1 reference
5 August 2005
1 reference
1 reference
16
1 reference
10
1 reference
1654-1661
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference